Drugdevelopment-technology.com

Drugdevelopment Technology. Medical devices, operations, supply chain, data, outsourcing and technology.

Never miss Drugdevelopment-technology.com updates: Start reading the news feed of Drugdevelopment Technology right away! This site’s feed is stale or rarely updated (or it might be broken for a reason), but you may check related news or Drugdevelopment-technology.com popular pages instead. It is generally safe for browsing, so you may click any item to proceed to the site.

News, stories and media buzz related to Drugdevelopment Technology

Subscribe to related news

DBV Technologies Receives FDA Breakthrough Therapy Designation for Viaskin Peanut for the Treatment of Peanut Allergy in...
via virtual.tdprofiti

BAGNEUX, France, April 9, 2015 (GLOBE NEWSWIRE) — DBV Technologies Receives FDA Breakthrough Therapy Designation for Viaskin Peanut for the Treatment of Peanut Allergy in Children DBV Technologies is the first company to announce Breakthrough Therapy...
Dermira announces positive Phase IIb results for DRM04 in Hyperhidrosis patients
via pharmaceutical-business-review

Dermira, a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and their patients, announced positive Phase IIb study results for DRM04, its proprietary topical anticholinergic product, in...
Consensus on the Development of Vaccines against Naturally Acquired Melioidosis - Volume 21, Number 6—June 2015 - Emergi...
via elbiruniblogspotcom.blogspot

Consensus on the Development of Vaccines against Naturally Acquired Melioidosis - Volume 21, Number 6—June 2015 - Emerging Infectious Disease journal - CDC Volume 21, Number 6—June 2015 Online Report Consensus on the Development of Vaccines against...
AIPGMEE 2004 Rapid Review
via desimedicos

Anatomy Integrity of long thoracic nerve after damage due to surgery can be tested bedside by asking patient to raise the arm above the head on the affected side. Inhaled foreign body is likely to lodge in right lung because of reasons that right principal...
Special Report: A World of Difference — Biosimilars and Biobetters Offer Unique Benefits — and Risks
via bioprocessintl

by John Otrompke, with Cheryl Scott and S. Anne Montgomery When the United States Food and Drug Administration (FDA) approved the country’s first ever biosimilar on 6 March 2015, it had been a long time coming. After all, the European Union had approved...

Drugdevelopment-technology.com popular pages

Exubera - Inhaled Insulin - Drug Development Technology

The product of a joint development programme between Aventis and Pfizer, Exubera is an inhaled short-acting insulin preparation indicated for the treatment of type 1 and type 2 diabetes. In adult type...
Xeljanz (tofacitinib) - Treatment for Rheumatoid Arthritis - Drug Development Technology

Xeljanz (tofacitinib) is a janus kinase (JAK) 3 inhibitor developed by Pfizer as a treatment for the symptoms of rheumatoid arthritis.The drug has been studied for the treatment of a number of other d...

Home - Clinical Trials Arena

Home Latest More themes More Insights Pharma Technology Focus Magazine Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest ...